Trials / Sponsors / Nathan Bahary, MD
Nathan Bahary, MD
Academic / Other · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Pre-Operative Trial (PGHA vs. PGH) for Resectable Pancreatic Cancer Pancreatic Cancer Resectable | Phase 2 | 2017-12-13 |
| Terminated | Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiat Borderline Resectable Pancreatic Cancer | Phase 2 | 2014-12-01 |
| Completed | A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangioc Metastatic Biliary Tract Carcinoma | Phase 2 | 2014-01-01 |
| Completed | Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine Pancreatic Cancer | Phase 2 | 2013-11-01 |